The historical rank and industry rank for DreamCIS's EV-to-EBIT or its related term are showing as below:
XKRX:223250'
s EV-to-EBIT Range Over the Past 10 Years
Min: 5.58 Med: 14.65 Max: 100.77
Current: 14.73
During the past 11 years, the highest EV-to-EBIT of DreamCIS was 100.77. The lowest was 5.58. And the median was 14.65.
XKRX:223250's EV-to-EBIT is ranked better than 59.91% of 429
companies
in the Healthcare Providers & Services industry
Industry Median: 18.01
vs XKRX:223250: 14.73
The historical data trend for DreamCIS's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, DreamCIS's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DreamCIS's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, DreamCIS's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where DreamCIS's EV-to-EBIT falls into.
DreamCIS's current Enterprise Value is ₩62,741 Mil.
DreamCIS's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩4,404 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DreamCIS (XKRX:223250) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
DreamCIS's Enterprise Value for the quarter that ended in Mar. 2024 was ₩56,179 Mil.
DreamCIS's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩4,404 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DreamCIS EV-to-EBIT Related Terms
Thank you for viewing the detailed overview of DreamCIS's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.
DreamCIS INC operates as a contract research organization. It provides experience services in Therapeutic Areas; Clinical Trial/Late Phase Study; Oncology; Cardiovascular; Endocrinology; and Rare Disease. It provides its services to clinical development; stand alone services; medical devices; and consulting.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XKRX:223250 has been successfully added to your 